梅斯病例报告001|非动脉炎性前部缺血性视神经病变

2021-05-19 Oranhgy MedSci原创

男,62岁,因“左眼出现视力障碍5d,加重1d“于2020年4月28日急诊科就诊。患者主诉前一天晚上睡觉前视力正常(戴双焦矫正眼镜)次日醒来时,左眼出现严重视力模糊。

男,62岁,因“左眼出现视力障碍5d,加重1d“于2020年4月28日急诊科就诊。患者主诉前一天晚上睡觉前视力正常(戴双焦矫正眼镜)次日醒来时,左眼出现严重视力模糊。

否认眼睛疼痛、发红、有分泌物,外伤(左眼或头部),或右眼受累。否认其他症状(包括肌肉无力、麻痹、面部受累、头痛、头晕,或最近的晕厥发作)。

既往史包括高血压,他在睡前服用赖诺普利20mg,以及2型糖尿病,他每天服用二甲双胍1g。没有服用其他药物。否认过去或现在有任何精神疾病。既往手术史:阑尾切除术(28岁)。无烟酒嗜好,否认使用非法药物。家族史没有任何关联性。

身体检查

检查时,他的生命体征正常。他的视力是20/160 OS(1年前OS是20/30),OD矫正后是20/30。他的眼外肌完好无损,眼压为15mmHg,属于正常范围。

P:88次/分,BP:140/82 mmHg ,R:14次/分。

患眼上视野缺损,右眼视野完好无损。患者的左眼被发现有相对传入性瞳孔缺陷(RAPD),也就是所谓的马库斯-冈恩瞳孔。左眼的眼底镜检查显示有一个小的、高渗的圆盘,边界无法辨别。右眼眼底镜检查和双侧裂隙灯检查均为阴性。其余的身体检查,包括神经系统检查,都是阴性的。

患者左眼眼底镜

诊断

由于有糖尿病和高血压等缺血性卒中的危险因素,因此进行大脑计算机断层扫描(CT)血管造影,结果是阴性。医生诊断患者为非动脉硬化性前部缺血性视神经病变(NAION)。

讨论

初级保健和急诊医学的临床医生应该熟悉常见的眼科疾病,如果及时转诊和治疗,可能有助于改善视力。缺血性视神经病变(ION)是50岁以上患者最常见的急性视神经病变,该年龄段的发病率估计为每年每10万人2.3至10.2例。

缺血性视神经病可分为前部(影响视神经的前部)或后部(影响视神经的球后部分)以及动脉性或非动脉性病变。

动脉炎性前部缺血性视神经病变(AAION)是颞部动脉炎患者视力下降的一个常见原因。颞动脉炎是一种医疗紧急情况,需要及时治疗以防止失明和中风。

非动脉性前部缺血性视神经病变是最常见的缺血性视神经病变。典型的表现包括急性、单侧、无痛性的中央和/或周边视力丧失。大约20%的NAION患者在初次就诊时的视力为20/200或更高,但在高达50%的病例中,视力可在30/64或更高之间变化。

非动脉硬化性前部缺血性视神经病变可发生在任何年龄段,但在老年白人中更为常见(平均发病年龄为60岁),男性比女性略为常见。非典患者通常表现为相对传入性瞳孔缺损(RAPD),眼底镜检查可发现弥漫性视盘水肿,并伴有表层出血。

NAION的基本病理机制尚不完全清楚。有研究表明,这种情况的发生可能是由于一过性的视神经前部灌注不足,尤其是在夜间,因为夜间低血压。此外,还有其他研究表明,NAION可能是由局部或全身的视神经头血流紊乱引起的,就像动脉硬化、血管痉挛、高血压和糖尿病所引起的那样。

其他与NAION有关的药物包括抗心律失常的胺碘酮和用于治疗勃起功能障碍的5型磷酸二酯酶抑制剂(PDE-5i)。5 NAION的自然病程可能包括多达43%的患者在没有药物干预的情况下出现不同的视觉改善。

诊断

NAION的诊断是临床性的,不推荐进行具体的实验室检查或影像学检查。然而,伴有非典型NAION症状的患者或有其他合并症风险因素的患者可能需要进行脑部CT成像以排除其他神经血管病变。

治疗方法

已对NAION的多种药物和手术治疗方案进行了测试,但没有一个被明确证明是有效的。目前有机构正在进行短程干扰核糖核酸(siRNA)的玻璃体内注射临床试验研究,但公布的数据有限。有研究表明,与自然病程相比,使用皮质类固醇治疗可以改善视觉功能。由于NAION的发病机制与脑血管中风不同,不建议对NAION进行抗凝、溶栓治疗和抗血小板治疗。

结论

遇到可能患有NAION的患者,临床医生必须首先排除AAION和其他神经血管病变。处理方法应该是评估和治疗可能导致NAION发生的潜在风险因素。应及时转诊到眼科医生处,并考虑在这些患者中继续使用PDE-5i药物的安全性。尽管没有临床治疗方法被证明是有效的,但口服皮质类固醇可能会缩短视盘水肿的持续时间,从而导致视力可能的改善。NAION的预后在不同的患者中是不同的。幸运的是,复发和对侧眼受累的情况很少。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (11)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2102978, encodeId=4a2821029e8fa, content=en, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e21a8452588, createdName=ms1000001512282914, createdTime=Sun Nov 27 23:56:55 CST 2022, time=2022-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2102975, encodeId=dd5921029e55f, content=喜欢, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e21a8452588, createdName=ms1000001512282914, createdTime=Sun Nov 27 23:53:15 CST 2022, time=2022-11-27, status=1, ipAttribution=日本), GetPortalCommentsPageByObjectIdResponse(id=1926549, encodeId=1e961926549ec, content=<a href='/topic/show?id=3ce590e1692' target=_blank style='color:#2F92EE;'>#视神经病变#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90716, encryptionId=3ce590e1692, topicName=视神经病变)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=991e83, createdName=wincls, createdTime=Tue Aug 03 08:00:11 CST 2021, time=2021-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1667018, encodeId=76e0166e018ef, content=<a href='/topic/show?id=5fda90e061e' target=_blank style='color:#2F92EE;'>#视神经#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90706, encryptionId=5fda90e061e, topicName=视神经)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14db26078051, createdName=gj0740, createdTime=Mon Jul 26 16:00:11 CST 2021, time=2021-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1683219, encodeId=d8971683219f1, content=<a href='/topic/show?id=60f03325e28' target=_blank style='color:#2F92EE;'>#动脉炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33257, encryptionId=60f03325e28, topicName=动脉炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d22a27947071, createdName=xsm927, createdTime=Thu Aug 19 20:00:11 CST 2021, time=2021-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1893382, encodeId=96941893382d1, content=<a href='/topic/show?id=c738e93521f' target=_blank style='color:#2F92EE;'>#缺血性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79352, encryptionId=c738e93521f, topicName=缺血性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Sun Apr 17 18:00:11 CST 2022, time=2022-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967455, encodeId=6ecb96e45553, content=有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210509/4dc6683c2d0d48aa82390909cd0b5d79/011b1dfcdd7246d1a6778fc5db2015eb.jpg, createdBy=91835495496, createdName=百灵鸟818, createdTime=Fri May 21 13:02:01 CST 2021, time=2021-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1277201, encodeId=104912e720108, content=<a href='/topic/show?id=bde16242956' target=_blank style='color:#2F92EE;'>#梅斯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62429, encryptionId=bde16242956, topicName=梅斯)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Fri May 21 03:00:11 CST 2021, time=2021-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1377046, encodeId=b30513e7046bf, content=<a href='/topic/show?id=8ff8e0777c5' target=_blank style='color:#2F92EE;'>#病例报告#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70777, encryptionId=8ff8e0777c5, topicName=病例报告)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8143398, createdName=lily1616, createdTime=Fri May 21 03:00:11 CST 2021, time=2021-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1491401, encodeId=ddbc149140123, content=<a href='/topic/show?id=5316e4387aa' target=_blank style='color:#2F92EE;'>#神经病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74387, encryptionId=5316e4387aa, topicName=神经病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1ab48885684, createdName=axin012, createdTime=Fri May 21 03:00:11 CST 2021, time=2021-05-21, status=1, ipAttribution=)]
    2022-11-27 ms1000001512282914

    en

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2102978, encodeId=4a2821029e8fa, content=en, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e21a8452588, createdName=ms1000001512282914, createdTime=Sun Nov 27 23:56:55 CST 2022, time=2022-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2102975, encodeId=dd5921029e55f, content=喜欢, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e21a8452588, createdName=ms1000001512282914, createdTime=Sun Nov 27 23:53:15 CST 2022, time=2022-11-27, status=1, ipAttribution=日本), GetPortalCommentsPageByObjectIdResponse(id=1926549, encodeId=1e961926549ec, content=<a href='/topic/show?id=3ce590e1692' target=_blank style='color:#2F92EE;'>#视神经病变#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90716, encryptionId=3ce590e1692, topicName=视神经病变)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=991e83, createdName=wincls, createdTime=Tue Aug 03 08:00:11 CST 2021, time=2021-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1667018, encodeId=76e0166e018ef, content=<a href='/topic/show?id=5fda90e061e' target=_blank style='color:#2F92EE;'>#视神经#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90706, encryptionId=5fda90e061e, topicName=视神经)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14db26078051, createdName=gj0740, createdTime=Mon Jul 26 16:00:11 CST 2021, time=2021-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1683219, encodeId=d8971683219f1, content=<a href='/topic/show?id=60f03325e28' target=_blank style='color:#2F92EE;'>#动脉炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33257, encryptionId=60f03325e28, topicName=动脉炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d22a27947071, createdName=xsm927, createdTime=Thu Aug 19 20:00:11 CST 2021, time=2021-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1893382, encodeId=96941893382d1, content=<a href='/topic/show?id=c738e93521f' target=_blank style='color:#2F92EE;'>#缺血性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79352, encryptionId=c738e93521f, topicName=缺血性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Sun Apr 17 18:00:11 CST 2022, time=2022-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967455, encodeId=6ecb96e45553, content=有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210509/4dc6683c2d0d48aa82390909cd0b5d79/011b1dfcdd7246d1a6778fc5db2015eb.jpg, createdBy=91835495496, createdName=百灵鸟818, createdTime=Fri May 21 13:02:01 CST 2021, time=2021-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1277201, encodeId=104912e720108, content=<a href='/topic/show?id=bde16242956' target=_blank style='color:#2F92EE;'>#梅斯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62429, encryptionId=bde16242956, topicName=梅斯)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Fri May 21 03:00:11 CST 2021, time=2021-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1377046, encodeId=b30513e7046bf, content=<a href='/topic/show?id=8ff8e0777c5' target=_blank style='color:#2F92EE;'>#病例报告#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70777, encryptionId=8ff8e0777c5, topicName=病例报告)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8143398, createdName=lily1616, createdTime=Fri May 21 03:00:11 CST 2021, time=2021-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1491401, encodeId=ddbc149140123, content=<a href='/topic/show?id=5316e4387aa' target=_blank style='color:#2F92EE;'>#神经病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74387, encryptionId=5316e4387aa, topicName=神经病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1ab48885684, createdName=axin012, createdTime=Fri May 21 03:00:11 CST 2021, time=2021-05-21, status=1, ipAttribution=)]
    2022-11-27 ms1000001512282914 来自日本

    喜欢

    1

    展开1条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2102978, encodeId=4a2821029e8fa, content=en, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e21a8452588, createdName=ms1000001512282914, createdTime=Sun Nov 27 23:56:55 CST 2022, time=2022-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2102975, encodeId=dd5921029e55f, content=喜欢, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e21a8452588, createdName=ms1000001512282914, createdTime=Sun Nov 27 23:53:15 CST 2022, time=2022-11-27, status=1, ipAttribution=日本), GetPortalCommentsPageByObjectIdResponse(id=1926549, encodeId=1e961926549ec, content=<a href='/topic/show?id=3ce590e1692' target=_blank style='color:#2F92EE;'>#视神经病变#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90716, encryptionId=3ce590e1692, topicName=视神经病变)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=991e83, createdName=wincls, createdTime=Tue Aug 03 08:00:11 CST 2021, time=2021-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1667018, encodeId=76e0166e018ef, content=<a href='/topic/show?id=5fda90e061e' target=_blank style='color:#2F92EE;'>#视神经#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90706, encryptionId=5fda90e061e, topicName=视神经)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14db26078051, createdName=gj0740, createdTime=Mon Jul 26 16:00:11 CST 2021, time=2021-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1683219, encodeId=d8971683219f1, content=<a href='/topic/show?id=60f03325e28' target=_blank style='color:#2F92EE;'>#动脉炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33257, encryptionId=60f03325e28, topicName=动脉炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d22a27947071, createdName=xsm927, createdTime=Thu Aug 19 20:00:11 CST 2021, time=2021-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1893382, encodeId=96941893382d1, content=<a href='/topic/show?id=c738e93521f' target=_blank style='color:#2F92EE;'>#缺血性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79352, encryptionId=c738e93521f, topicName=缺血性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Sun Apr 17 18:00:11 CST 2022, time=2022-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967455, encodeId=6ecb96e45553, content=有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210509/4dc6683c2d0d48aa82390909cd0b5d79/011b1dfcdd7246d1a6778fc5db2015eb.jpg, createdBy=91835495496, createdName=百灵鸟818, createdTime=Fri May 21 13:02:01 CST 2021, time=2021-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1277201, encodeId=104912e720108, content=<a href='/topic/show?id=bde16242956' target=_blank style='color:#2F92EE;'>#梅斯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62429, encryptionId=bde16242956, topicName=梅斯)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Fri May 21 03:00:11 CST 2021, time=2021-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1377046, encodeId=b30513e7046bf, content=<a href='/topic/show?id=8ff8e0777c5' target=_blank style='color:#2F92EE;'>#病例报告#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70777, encryptionId=8ff8e0777c5, topicName=病例报告)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8143398, createdName=lily1616, createdTime=Fri May 21 03:00:11 CST 2021, time=2021-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1491401, encodeId=ddbc149140123, content=<a href='/topic/show?id=5316e4387aa' target=_blank style='color:#2F92EE;'>#神经病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74387, encryptionId=5316e4387aa, topicName=神经病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1ab48885684, createdName=axin012, createdTime=Fri May 21 03:00:11 CST 2021, time=2021-05-21, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=2102978, encodeId=4a2821029e8fa, content=en, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e21a8452588, createdName=ms1000001512282914, createdTime=Sun Nov 27 23:56:55 CST 2022, time=2022-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2102975, encodeId=dd5921029e55f, content=喜欢, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e21a8452588, createdName=ms1000001512282914, createdTime=Sun Nov 27 23:53:15 CST 2022, time=2022-11-27, status=1, ipAttribution=日本), GetPortalCommentsPageByObjectIdResponse(id=1926549, encodeId=1e961926549ec, content=<a href='/topic/show?id=3ce590e1692' target=_blank style='color:#2F92EE;'>#视神经病变#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90716, encryptionId=3ce590e1692, topicName=视神经病变)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=991e83, createdName=wincls, createdTime=Tue Aug 03 08:00:11 CST 2021, time=2021-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1667018, encodeId=76e0166e018ef, content=<a href='/topic/show?id=5fda90e061e' target=_blank style='color:#2F92EE;'>#视神经#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90706, encryptionId=5fda90e061e, topicName=视神经)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14db26078051, createdName=gj0740, createdTime=Mon Jul 26 16:00:11 CST 2021, time=2021-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1683219, encodeId=d8971683219f1, content=<a href='/topic/show?id=60f03325e28' target=_blank style='color:#2F92EE;'>#动脉炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33257, encryptionId=60f03325e28, topicName=动脉炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d22a27947071, createdName=xsm927, createdTime=Thu Aug 19 20:00:11 CST 2021, time=2021-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1893382, encodeId=96941893382d1, content=<a href='/topic/show?id=c738e93521f' target=_blank style='color:#2F92EE;'>#缺血性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79352, encryptionId=c738e93521f, topicName=缺血性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Sun Apr 17 18:00:11 CST 2022, time=2022-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967455, encodeId=6ecb96e45553, content=有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210509/4dc6683c2d0d48aa82390909cd0b5d79/011b1dfcdd7246d1a6778fc5db2015eb.jpg, createdBy=91835495496, createdName=百灵鸟818, createdTime=Fri May 21 13:02:01 CST 2021, time=2021-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1277201, encodeId=104912e720108, content=<a href='/topic/show?id=bde16242956' target=_blank style='color:#2F92EE;'>#梅斯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62429, encryptionId=bde16242956, topicName=梅斯)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Fri May 21 03:00:11 CST 2021, time=2021-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1377046, encodeId=b30513e7046bf, content=<a href='/topic/show?id=8ff8e0777c5' target=_blank style='color:#2F92EE;'>#病例报告#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70777, encryptionId=8ff8e0777c5, topicName=病例报告)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8143398, createdName=lily1616, createdTime=Fri May 21 03:00:11 CST 2021, time=2021-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1491401, encodeId=ddbc149140123, content=<a href='/topic/show?id=5316e4387aa' target=_blank style='color:#2F92EE;'>#神经病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74387, encryptionId=5316e4387aa, topicName=神经病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1ab48885684, createdName=axin012, createdTime=Fri May 21 03:00:11 CST 2021, time=2021-05-21, status=1, ipAttribution=)]
    2021-07-26 gj0740
  5. [GetPortalCommentsPageByObjectIdResponse(id=2102978, encodeId=4a2821029e8fa, content=en, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e21a8452588, createdName=ms1000001512282914, createdTime=Sun Nov 27 23:56:55 CST 2022, time=2022-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2102975, encodeId=dd5921029e55f, content=喜欢, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e21a8452588, createdName=ms1000001512282914, createdTime=Sun Nov 27 23:53:15 CST 2022, time=2022-11-27, status=1, ipAttribution=日本), GetPortalCommentsPageByObjectIdResponse(id=1926549, encodeId=1e961926549ec, content=<a href='/topic/show?id=3ce590e1692' target=_blank style='color:#2F92EE;'>#视神经病变#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90716, encryptionId=3ce590e1692, topicName=视神经病变)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=991e83, createdName=wincls, createdTime=Tue Aug 03 08:00:11 CST 2021, time=2021-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1667018, encodeId=76e0166e018ef, content=<a href='/topic/show?id=5fda90e061e' target=_blank style='color:#2F92EE;'>#视神经#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90706, encryptionId=5fda90e061e, topicName=视神经)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14db26078051, createdName=gj0740, createdTime=Mon Jul 26 16:00:11 CST 2021, time=2021-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1683219, encodeId=d8971683219f1, content=<a href='/topic/show?id=60f03325e28' target=_blank style='color:#2F92EE;'>#动脉炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33257, encryptionId=60f03325e28, topicName=动脉炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d22a27947071, createdName=xsm927, createdTime=Thu Aug 19 20:00:11 CST 2021, time=2021-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1893382, encodeId=96941893382d1, content=<a href='/topic/show?id=c738e93521f' target=_blank style='color:#2F92EE;'>#缺血性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79352, encryptionId=c738e93521f, topicName=缺血性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Sun Apr 17 18:00:11 CST 2022, time=2022-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967455, encodeId=6ecb96e45553, content=有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210509/4dc6683c2d0d48aa82390909cd0b5d79/011b1dfcdd7246d1a6778fc5db2015eb.jpg, createdBy=91835495496, createdName=百灵鸟818, createdTime=Fri May 21 13:02:01 CST 2021, time=2021-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1277201, encodeId=104912e720108, content=<a href='/topic/show?id=bde16242956' target=_blank style='color:#2F92EE;'>#梅斯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62429, encryptionId=bde16242956, topicName=梅斯)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Fri May 21 03:00:11 CST 2021, time=2021-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1377046, encodeId=b30513e7046bf, content=<a href='/topic/show?id=8ff8e0777c5' target=_blank style='color:#2F92EE;'>#病例报告#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70777, encryptionId=8ff8e0777c5, topicName=病例报告)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8143398, createdName=lily1616, createdTime=Fri May 21 03:00:11 CST 2021, time=2021-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1491401, encodeId=ddbc149140123, content=<a href='/topic/show?id=5316e4387aa' target=_blank style='color:#2F92EE;'>#神经病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74387, encryptionId=5316e4387aa, topicName=神经病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1ab48885684, createdName=axin012, createdTime=Fri May 21 03:00:11 CST 2021, time=2021-05-21, status=1, ipAttribution=)]
    2021-08-19 xsm927
  6. [GetPortalCommentsPageByObjectIdResponse(id=2102978, encodeId=4a2821029e8fa, content=en, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e21a8452588, createdName=ms1000001512282914, createdTime=Sun Nov 27 23:56:55 CST 2022, time=2022-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2102975, encodeId=dd5921029e55f, content=喜欢, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e21a8452588, createdName=ms1000001512282914, createdTime=Sun Nov 27 23:53:15 CST 2022, time=2022-11-27, status=1, ipAttribution=日本), GetPortalCommentsPageByObjectIdResponse(id=1926549, encodeId=1e961926549ec, content=<a href='/topic/show?id=3ce590e1692' target=_blank style='color:#2F92EE;'>#视神经病变#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90716, encryptionId=3ce590e1692, topicName=视神经病变)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=991e83, createdName=wincls, createdTime=Tue Aug 03 08:00:11 CST 2021, time=2021-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1667018, encodeId=76e0166e018ef, content=<a href='/topic/show?id=5fda90e061e' target=_blank style='color:#2F92EE;'>#视神经#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90706, encryptionId=5fda90e061e, topicName=视神经)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14db26078051, createdName=gj0740, createdTime=Mon Jul 26 16:00:11 CST 2021, time=2021-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1683219, encodeId=d8971683219f1, content=<a href='/topic/show?id=60f03325e28' target=_blank style='color:#2F92EE;'>#动脉炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33257, encryptionId=60f03325e28, topicName=动脉炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d22a27947071, createdName=xsm927, createdTime=Thu Aug 19 20:00:11 CST 2021, time=2021-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1893382, encodeId=96941893382d1, content=<a href='/topic/show?id=c738e93521f' target=_blank style='color:#2F92EE;'>#缺血性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79352, encryptionId=c738e93521f, topicName=缺血性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Sun Apr 17 18:00:11 CST 2022, time=2022-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967455, encodeId=6ecb96e45553, content=有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210509/4dc6683c2d0d48aa82390909cd0b5d79/011b1dfcdd7246d1a6778fc5db2015eb.jpg, createdBy=91835495496, createdName=百灵鸟818, createdTime=Fri May 21 13:02:01 CST 2021, time=2021-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1277201, encodeId=104912e720108, content=<a href='/topic/show?id=bde16242956' target=_blank style='color:#2F92EE;'>#梅斯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62429, encryptionId=bde16242956, topicName=梅斯)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Fri May 21 03:00:11 CST 2021, time=2021-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1377046, encodeId=b30513e7046bf, content=<a href='/topic/show?id=8ff8e0777c5' target=_blank style='color:#2F92EE;'>#病例报告#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70777, encryptionId=8ff8e0777c5, topicName=病例报告)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8143398, createdName=lily1616, createdTime=Fri May 21 03:00:11 CST 2021, time=2021-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1491401, encodeId=ddbc149140123, content=<a href='/topic/show?id=5316e4387aa' target=_blank style='color:#2F92EE;'>#神经病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74387, encryptionId=5316e4387aa, topicName=神经病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1ab48885684, createdName=axin012, createdTime=Fri May 21 03:00:11 CST 2021, time=2021-05-21, status=1, ipAttribution=)]
  7. [GetPortalCommentsPageByObjectIdResponse(id=2102978, encodeId=4a2821029e8fa, content=en, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e21a8452588, createdName=ms1000001512282914, createdTime=Sun Nov 27 23:56:55 CST 2022, time=2022-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2102975, encodeId=dd5921029e55f, content=喜欢, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e21a8452588, createdName=ms1000001512282914, createdTime=Sun Nov 27 23:53:15 CST 2022, time=2022-11-27, status=1, ipAttribution=日本), GetPortalCommentsPageByObjectIdResponse(id=1926549, encodeId=1e961926549ec, content=<a href='/topic/show?id=3ce590e1692' target=_blank style='color:#2F92EE;'>#视神经病变#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90716, encryptionId=3ce590e1692, topicName=视神经病变)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=991e83, createdName=wincls, createdTime=Tue Aug 03 08:00:11 CST 2021, time=2021-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1667018, encodeId=76e0166e018ef, content=<a href='/topic/show?id=5fda90e061e' target=_blank style='color:#2F92EE;'>#视神经#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90706, encryptionId=5fda90e061e, topicName=视神经)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14db26078051, createdName=gj0740, createdTime=Mon Jul 26 16:00:11 CST 2021, time=2021-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1683219, encodeId=d8971683219f1, content=<a href='/topic/show?id=60f03325e28' target=_blank style='color:#2F92EE;'>#动脉炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33257, encryptionId=60f03325e28, topicName=动脉炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d22a27947071, createdName=xsm927, createdTime=Thu Aug 19 20:00:11 CST 2021, time=2021-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1893382, encodeId=96941893382d1, content=<a href='/topic/show?id=c738e93521f' target=_blank style='color:#2F92EE;'>#缺血性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79352, encryptionId=c738e93521f, topicName=缺血性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Sun Apr 17 18:00:11 CST 2022, time=2022-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967455, encodeId=6ecb96e45553, content=有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210509/4dc6683c2d0d48aa82390909cd0b5d79/011b1dfcdd7246d1a6778fc5db2015eb.jpg, createdBy=91835495496, createdName=百灵鸟818, createdTime=Fri May 21 13:02:01 CST 2021, time=2021-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1277201, encodeId=104912e720108, content=<a href='/topic/show?id=bde16242956' target=_blank style='color:#2F92EE;'>#梅斯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62429, encryptionId=bde16242956, topicName=梅斯)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Fri May 21 03:00:11 CST 2021, time=2021-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1377046, encodeId=b30513e7046bf, content=<a href='/topic/show?id=8ff8e0777c5' target=_blank style='color:#2F92EE;'>#病例报告#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70777, encryptionId=8ff8e0777c5, topicName=病例报告)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8143398, createdName=lily1616, createdTime=Fri May 21 03:00:11 CST 2021, time=2021-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1491401, encodeId=ddbc149140123, content=<a href='/topic/show?id=5316e4387aa' target=_blank style='color:#2F92EE;'>#神经病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74387, encryptionId=5316e4387aa, topicName=神经病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1ab48885684, createdName=axin012, createdTime=Fri May 21 03:00:11 CST 2021, time=2021-05-21, status=1, ipAttribution=)]
    2021-05-21 百灵鸟818

    有用

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=2102978, encodeId=4a2821029e8fa, content=en, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e21a8452588, createdName=ms1000001512282914, createdTime=Sun Nov 27 23:56:55 CST 2022, time=2022-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2102975, encodeId=dd5921029e55f, content=喜欢, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e21a8452588, createdName=ms1000001512282914, createdTime=Sun Nov 27 23:53:15 CST 2022, time=2022-11-27, status=1, ipAttribution=日本), GetPortalCommentsPageByObjectIdResponse(id=1926549, encodeId=1e961926549ec, content=<a href='/topic/show?id=3ce590e1692' target=_blank style='color:#2F92EE;'>#视神经病变#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90716, encryptionId=3ce590e1692, topicName=视神经病变)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=991e83, createdName=wincls, createdTime=Tue Aug 03 08:00:11 CST 2021, time=2021-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1667018, encodeId=76e0166e018ef, content=<a href='/topic/show?id=5fda90e061e' target=_blank style='color:#2F92EE;'>#视神经#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90706, encryptionId=5fda90e061e, topicName=视神经)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14db26078051, createdName=gj0740, createdTime=Mon Jul 26 16:00:11 CST 2021, time=2021-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1683219, encodeId=d8971683219f1, content=<a href='/topic/show?id=60f03325e28' target=_blank style='color:#2F92EE;'>#动脉炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33257, encryptionId=60f03325e28, topicName=动脉炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d22a27947071, createdName=xsm927, createdTime=Thu Aug 19 20:00:11 CST 2021, time=2021-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1893382, encodeId=96941893382d1, content=<a href='/topic/show?id=c738e93521f' target=_blank style='color:#2F92EE;'>#缺血性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79352, encryptionId=c738e93521f, topicName=缺血性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Sun Apr 17 18:00:11 CST 2022, time=2022-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967455, encodeId=6ecb96e45553, content=有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210509/4dc6683c2d0d48aa82390909cd0b5d79/011b1dfcdd7246d1a6778fc5db2015eb.jpg, createdBy=91835495496, createdName=百灵鸟818, createdTime=Fri May 21 13:02:01 CST 2021, time=2021-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1277201, encodeId=104912e720108, content=<a href='/topic/show?id=bde16242956' target=_blank style='color:#2F92EE;'>#梅斯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62429, encryptionId=bde16242956, topicName=梅斯)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Fri May 21 03:00:11 CST 2021, time=2021-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1377046, encodeId=b30513e7046bf, content=<a href='/topic/show?id=8ff8e0777c5' target=_blank style='color:#2F92EE;'>#病例报告#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70777, encryptionId=8ff8e0777c5, topicName=病例报告)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8143398, createdName=lily1616, createdTime=Fri May 21 03:00:11 CST 2021, time=2021-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1491401, encodeId=ddbc149140123, content=<a href='/topic/show?id=5316e4387aa' target=_blank style='color:#2F92EE;'>#神经病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74387, encryptionId=5316e4387aa, topicName=神经病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1ab48885684, createdName=axin012, createdTime=Fri May 21 03:00:11 CST 2021, time=2021-05-21, status=1, ipAttribution=)]
    2021-05-21 一闲
  9. [GetPortalCommentsPageByObjectIdResponse(id=2102978, encodeId=4a2821029e8fa, content=en, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e21a8452588, createdName=ms1000001512282914, createdTime=Sun Nov 27 23:56:55 CST 2022, time=2022-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2102975, encodeId=dd5921029e55f, content=喜欢, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e21a8452588, createdName=ms1000001512282914, createdTime=Sun Nov 27 23:53:15 CST 2022, time=2022-11-27, status=1, ipAttribution=日本), GetPortalCommentsPageByObjectIdResponse(id=1926549, encodeId=1e961926549ec, content=<a href='/topic/show?id=3ce590e1692' target=_blank style='color:#2F92EE;'>#视神经病变#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90716, encryptionId=3ce590e1692, topicName=视神经病变)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=991e83, createdName=wincls, createdTime=Tue Aug 03 08:00:11 CST 2021, time=2021-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1667018, encodeId=76e0166e018ef, content=<a href='/topic/show?id=5fda90e061e' target=_blank style='color:#2F92EE;'>#视神经#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90706, encryptionId=5fda90e061e, topicName=视神经)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14db26078051, createdName=gj0740, createdTime=Mon Jul 26 16:00:11 CST 2021, time=2021-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1683219, encodeId=d8971683219f1, content=<a href='/topic/show?id=60f03325e28' target=_blank style='color:#2F92EE;'>#动脉炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33257, encryptionId=60f03325e28, topicName=动脉炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d22a27947071, createdName=xsm927, createdTime=Thu Aug 19 20:00:11 CST 2021, time=2021-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1893382, encodeId=96941893382d1, content=<a href='/topic/show?id=c738e93521f' target=_blank style='color:#2F92EE;'>#缺血性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79352, encryptionId=c738e93521f, topicName=缺血性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Sun Apr 17 18:00:11 CST 2022, time=2022-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967455, encodeId=6ecb96e45553, content=有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210509/4dc6683c2d0d48aa82390909cd0b5d79/011b1dfcdd7246d1a6778fc5db2015eb.jpg, createdBy=91835495496, createdName=百灵鸟818, createdTime=Fri May 21 13:02:01 CST 2021, time=2021-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1277201, encodeId=104912e720108, content=<a href='/topic/show?id=bde16242956' target=_blank style='color:#2F92EE;'>#梅斯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62429, encryptionId=bde16242956, topicName=梅斯)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Fri May 21 03:00:11 CST 2021, time=2021-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1377046, encodeId=b30513e7046bf, content=<a href='/topic/show?id=8ff8e0777c5' target=_blank style='color:#2F92EE;'>#病例报告#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70777, encryptionId=8ff8e0777c5, topicName=病例报告)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8143398, createdName=lily1616, createdTime=Fri May 21 03:00:11 CST 2021, time=2021-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1491401, encodeId=ddbc149140123, content=<a href='/topic/show?id=5316e4387aa' target=_blank style='color:#2F92EE;'>#神经病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74387, encryptionId=5316e4387aa, topicName=神经病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1ab48885684, createdName=axin012, createdTime=Fri May 21 03:00:11 CST 2021, time=2021-05-21, status=1, ipAttribution=)]
  10. [GetPortalCommentsPageByObjectIdResponse(id=2102978, encodeId=4a2821029e8fa, content=en, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e21a8452588, createdName=ms1000001512282914, createdTime=Sun Nov 27 23:56:55 CST 2022, time=2022-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2102975, encodeId=dd5921029e55f, content=喜欢, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e21a8452588, createdName=ms1000001512282914, createdTime=Sun Nov 27 23:53:15 CST 2022, time=2022-11-27, status=1, ipAttribution=日本), GetPortalCommentsPageByObjectIdResponse(id=1926549, encodeId=1e961926549ec, content=<a href='/topic/show?id=3ce590e1692' target=_blank style='color:#2F92EE;'>#视神经病变#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90716, encryptionId=3ce590e1692, topicName=视神经病变)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=991e83, createdName=wincls, createdTime=Tue Aug 03 08:00:11 CST 2021, time=2021-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1667018, encodeId=76e0166e018ef, content=<a href='/topic/show?id=5fda90e061e' target=_blank style='color:#2F92EE;'>#视神经#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90706, encryptionId=5fda90e061e, topicName=视神经)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14db26078051, createdName=gj0740, createdTime=Mon Jul 26 16:00:11 CST 2021, time=2021-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1683219, encodeId=d8971683219f1, content=<a href='/topic/show?id=60f03325e28' target=_blank style='color:#2F92EE;'>#动脉炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33257, encryptionId=60f03325e28, topicName=动脉炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d22a27947071, createdName=xsm927, createdTime=Thu Aug 19 20:00:11 CST 2021, time=2021-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1893382, encodeId=96941893382d1, content=<a href='/topic/show?id=c738e93521f' target=_blank style='color:#2F92EE;'>#缺血性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79352, encryptionId=c738e93521f, topicName=缺血性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Sun Apr 17 18:00:11 CST 2022, time=2022-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967455, encodeId=6ecb96e45553, content=有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210509/4dc6683c2d0d48aa82390909cd0b5d79/011b1dfcdd7246d1a6778fc5db2015eb.jpg, createdBy=91835495496, createdName=百灵鸟818, createdTime=Fri May 21 13:02:01 CST 2021, time=2021-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1277201, encodeId=104912e720108, content=<a href='/topic/show?id=bde16242956' target=_blank style='color:#2F92EE;'>#梅斯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62429, encryptionId=bde16242956, topicName=梅斯)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Fri May 21 03:00:11 CST 2021, time=2021-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1377046, encodeId=b30513e7046bf, content=<a href='/topic/show?id=8ff8e0777c5' target=_blank style='color:#2F92EE;'>#病例报告#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70777, encryptionId=8ff8e0777c5, topicName=病例报告)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8143398, createdName=lily1616, createdTime=Fri May 21 03:00:11 CST 2021, time=2021-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1491401, encodeId=ddbc149140123, content=<a href='/topic/show?id=5316e4387aa' target=_blank style='color:#2F92EE;'>#神经病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74387, encryptionId=5316e4387aa, topicName=神经病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1ab48885684, createdName=axin012, createdTime=Fri May 21 03:00:11 CST 2021, time=2021-05-21, status=1, ipAttribution=)]
    2021-05-21 axin012

相关资讯

病例讨论:胃上皮内肿瘤

    病理初尝   拨云见日   病历简介   患者男性,63岁,因上腹不适2个月就诊。胃镜检查显示:胃窦多发片状红斑糜烂,局部取活检。   这些细胞核的表现没有明显的异型性,不支持肿瘤性病变。再看活检表面,有些炎性分泌物,表面不完整,看不出有无成熟趋势,对诊断没有什么实质性帮助。此时,诊断遇到了很大困难,病变结构异常与细胞改变不一致,到底能否诊断上皮内肿瘤?确诊的决心很难下

临床病例讨论规范流程

临床病例讨论是毕业实习阶段培养学生临床诊断、治疗、预后估计等决策思维的重要教学活动之一。其目的在于培养实习生学习医学前辈、上级医师和同学间的知识经验,学习分析和解决临床问题的能力,锻炼自学和口头表达能力。 临床病历讨论实施以启发讨论式教学方法为主,体现教师与学生的互动性,是以学生为主体,教师为媒体,知识为客体的全新教学模式。临床病案讨论包括:典型病例、疑难病例、死亡病例讨论等。各病区的临床教学病

临床病例讨论——腹胀、腹水、腹膜后囊肿、多发骨质破坏

患者男,57岁。因“腹胀1个月,双下肢水肿1 d”于2011年11月25日入院。患者1个月前无明显诱因出现腹部胀满不适,无腹痛,无呕血、黑便,自服多潘立酮疗效不显,腹胀呈进行性加重,以“腹胀 原因待查”收入院。自发病以来患者精神、饮食、睡眠欠佳,大小便无异常,体重无明显增减。既往慢性咳嗽、咯痰5年余,以冬季较重,否认糖尿病史。个人史: 吸烟38年,40支/d,饮酒38年,300~350

病例讨论:头晕耳鸣胸闷心悸

       病历摘要   主诉   患者,老年女性,67岁。因“反复头晕、耳鸣10年,胸闷、心悸2年,加重2周”入院。   现病史   10年前开始出现反复头晕、眼花、耳鸣,在当地医院查血压升高,最高达180/100 mmHg,曾服用珍菊降压片、钙离子拮抗剂(CCB)等治疗,但血压控制不稳定。近2年出现胸闷、心悸,近2周上述症状加重,测血压160~170/100~116&nb

NEJM病例讨论:24岁男性发烧,咳嗽和呼吸困难,是新冠肺炎?

一名24岁的男子因发热、乏力、咳嗽、呼吸困难转入该院就诊。

病例讨论:介入还是手术?

  病例简介   患者女,27岁,因“发作性头晕、晕厥8年,胸闷1年余,加重伴胸痛2个月”于2010年7月17日入院。   既往史:否认高血压、糖尿病、冠心病、高脂血症、肝炎、结核病史;否认外伤、手术、输血史;否认药物及食物过敏史。个人史:不嗜烟酒。婚育史:G2P0,第一胎自然流产。家族史无特殊。   2002年   患者无明显诱因出现发作性头晕、视物不清,持续1~2分钟后自行好转,曾有1